Patrick D. Walsh, Director at ANI PHARMACEUTICALS INC (ANIP), bought 5,000 shares at $27.76 ($139K) on 2022-03-21, disclosed to the SEC on 2022-03-22.
Open-market purchase of $139k ANIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ANIP | SELL | 2025-11-17 | $1.5M | — | Filing → |
| ANIP | SELL | 2025-08-18 | $801K | — | Filing → |
| LNDC | BUY | 2021-04-22 | $113K | — | Filing → |